Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
Keywords:
Dendritic cells
Renal cell carcinoma
VEGF
Bevacizumab
Sunitinib
Sorafenib
Publisher:
Cancer Research UK
Citation:
Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, Dubrot J, et al. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 2009 Apr 7;100(7):1111-1119.
Files in This Item:
There are no files associated with this item.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.